Class & Mechanism — Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide that stimulates the immune system, particularly the production of T cells, and has anti-inflammatory and antioxidant properties.
Research-documented benefits — [8] Stimulates the immune system; [8] Fights liver and kidney disease, rheumatoid arthritis; [8] FDA-approved for malignant melanoma, hepatitis B, and hepatitis C.
General-knowledge benefits — Tα1 is known for its role in immunological aging and its potential to combat infections and diseases associated with a weakened immune system.
Typical injectable protocol — Research-only, experimental. Dosing information is not available in the provided excerpts.
Key risks / contraindications — No specific risks mentioned in the provided excerpts.
Bottom line — Thymosin Alpha-1 is a peptide with potential immune-stimulating properties, but its use in humans requires further research.
References
- Antimicrobial Peptides and Human Disease
- Antimicrobial Peptides_ Basics for Clinical Application
- Antimicrobial peptides and the skin immune defense system
- Antimicrobial peptides from plants with potential against multidrug-resistant bacteria
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Click Chemistry_ A Universal Ligation Strategy
- GHK Peptide as a Natural Modulator of Multiple Cellular — Loren Pickart
- Handbook of Biologically Active Peptides
- Kosmetik für Ärzte und Apotheker
- Life Force
- Living a Fully Optimized Life
- Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
- Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
- Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
- Peptide Protocols Volume One — William A Seeds MD
- Peptide therapy with pentadecapeptide BPC 157 in traumatic — Gjurasin, Miroslav
- Rook's Textbook of Dermatology
- The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
- The pharmacological properties of the novel peptide BPC 157 — P Sikiric（Affiliation Department of Pharmacology, Medical
- Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor